Recurrent Early Coronary Stent Thrombosis under Chronic Disseminated Intravascular Coagulation

Yusuke Oba1, Satoshi Hoshide1, Tadayuki Mitama1

  • 1Division of Cardiovascular Medicine, Department of Internal Medicine, Jichi Medical University School of Medicine.

International Heart Journal
|November 23, 2017
PubMed

Insights

Chronic DIC may cause recurrent stent thrombosis after percutaneous coronary intervention (PCI). Anticoagulation with warfarin, in addition to antiplatelet therapy, may prevent stent thrombosis in patients with disseminated intravascular coagulation (DIC).

Area of Science:

  • Cardiology
  • Hematology

Background:

  • A 62-year-old man with a history of splenectomy for idiopathic portal hypertension presented with acute myocardial infarction.
  • Coronary angiography revealed diffuse stenosis and calcification in the left anterior descending artery (LAD).

Observation:

  • Initial percutaneous coronary intervention (PCI) with drug-eluting stents was performed.
  • The patient developed early coronary stent thrombosis despite dual antiplatelet therapy, requiring a second PCI.
  • A second episode of stent thrombosis occurred, necessitating a third PCI.

Findings:

  • Laboratory examination revealed chronic disseminated intravascular coagulation (DIC).
  • Portal vein thrombosis was identified on contrast-enhanced CT.
  • Anticoagulation with warfarin, alongside antiplatelet therapy, led to DIC improvement and no recurrent stent thrombosis for one month.

Implications:

  • This case suggests that chronic disseminated intravascular coagulation (DIC) may be a contributing factor to recurrent stent thrombosis.
  • Anticoagulation therapy, in addition to dual antiplatelet therapy, could be a potential treatment strategy to prevent stent thrombosis in patients with DIC.
  • Stent thrombosis, though infrequent, is a serious complication associated with significant morbidity and mortality.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
388
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
504
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
477
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
314
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
309